News
-
-
-
COMMUNIQUÉ DE PRESSE
Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada
Septa Pharmaceuticals Inc. successfully acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada, reinforcing its specialty oncology pharmaceutical portfolio and commitment to patient care